Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type (2014-2025) 1.4.2 Biologics 1.4.3 Small Molecule Targeted Therapy 1.4.4 Chemotherapy 1.4.5 Other 1.5 Market by Application 1.5.1 Global Non-small Cell Lung Cancer Drugs Market Share by Application (2019-2025) 1.5.2 Lung Adenocarcinoma 1.5.3 Squamous Cell Lung Carcinoma 1.5.4 Large-cell Lung Carcinoma 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Non-small Cell Lung Cancer Drugs Market Size 2.2 Non-small Cell Lung Cancer Drugs Growth Trends by Regions 2.2.1 Non-small Cell Lung Cancer Drugs Market Size by Regions (2019-2025) 2.2.2 Non-small Cell Lung Cancer Drugs Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 3 Market Share by Key Players 3.1 Non-small Cell Lung Cancer Drugs Market Size by by Players 3.1.1 Global Non-small Cell Lung Cancer Drugs Revenue by by Players (2014-2019) 3.1.2 Global Non-small Cell Lung Cancer Drugs Revenue Market Share by by Players (2014-2019) 3.1.3 Global Non-small Cell Lung Cancer Drugs Market Concentration Ratio (CR5 and HHI) 3.2 Non-small Cell Lung Cancer Drugs Key Players Head office and Area Served 3.3 Key Players Non-small Cell Lung Cancer Drugs Product/Solution/Service 3.4 Date of Enter into Non-small Cell Lung Cancer Drugs Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Non-small Cell Lung Cancer Drugs Market Size by Type (2014-2019) 4.2 Global Non-small Cell Lung Cancer Drugs Market Size by Application (2014-2019) 5 North America 5.1 North America Non-small Cell Lung Cancer Drugs Market Size (2014-2019) 5.2 Non-small Cell Lung Cancer Drugs Key Players in North America 5.3 North America Non-small Cell Lung Cancer Drugs Market Size by Type 5.4 North America Non-small Cell Lung Cancer Drugs Market Size by Application 6 Europe 6.1 Europe Non-small Cell Lung Cancer Drugs Market Size (2014-2019) 6.2 Non-small Cell Lung Cancer Drugs Key Players in Europe 6.3 Europe Non-small Cell Lung Cancer Drugs Market Size by Type 6.4 Europe Non-small Cell Lung Cancer Drugs Market Size by Application 7 China 7.1 China Non-small Cell Lung Cancer Drugs Market Size (2014-2019) 7.2 Non-small Cell Lung Cancer Drugs Key Players in China 7.3 China Non-small Cell Lung Cancer Drugs Market Size by Type 7.4 China Non-small Cell Lung Cancer Drugs Market Size by Application 8 Japan 8.1 Japan Non-small Cell Lung Cancer Drugs Market Size (2014-2019) 8.2 Non-small Cell Lung Cancer Drugs Key Players in Japan 8.3 Japan Non-small Cell Lung Cancer Drugs Market Size by Type 8.4 Japan Non-small Cell Lung Cancer Drugs Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size (2014-2019) 9.2 Non-small Cell Lung Cancer Drugs Key Players in Southeast Asia 9.3 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Type 9.4 Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Application 10 India 10.1 India Non-small Cell Lung Cancer Drugs Market Size (2014-2019) 10.2 Non-small Cell Lung Cancer Drugs Key Players in India 10.3 India Non-small Cell Lung Cancer Drugs Market Size by Type 10.4 India Non-small Cell Lung Cancer Drugs Market Size by Application 11 Central & South America 11.1 Central & South America Non-small Cell Lung Cancer Drugs Market Size (2014-2019) 11.2 Non-small Cell Lung Cancer Drugs Key Players in Central & South America 11.3 Central & South America Non-small Cell Lung Cancer Drugs Market Size by Type 11.4 Central & South America Non-small Cell Lung Cancer Drugs Market Size by Application 12 International Players Profiles 12.1 AstraZeneca 12.1.1 AstraZeneca Company Details 12.1.2 Company Description and Business Overview 12.1.3 Non-small Cell Lung Cancer Drugs Introduction 12.1.4 AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019)) 12.1.5 AstraZeneca Recent Development 12.2 Bristol-Myers Squibb Company 12.2.1 Bristol-Myers Squibb Company Company Details 12.2.2 Company Description and Business Overview 12.2.3 Non-small Cell Lung Cancer Drugs Introduction 12.2.4 Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019) 12.2.5 Bristol-Myers Squibb Company Recent Development 12.3 Eli Lilly and Company 12.3.1 Eli Lilly and Company Company Details 12.3.2 Company Description and Business Overview 12.3.3 Non-small Cell Lung Cancer Drugs Introduction 12.3.4 Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019) 12.3.5 Eli Lilly and Company Recent Development 12.4 F. Hoffmann-La Roche Ltd 12.4.1 F. Hoffmann-La Roche Ltd Company Details 12.4.2 Company Description and Business Overview 12.4.3 Non-small Cell Lung Cancer Drugs Introduction 12.4.4 F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019) 12.4.5 F. Hoffmann-La Roche Ltd Recent Development 12.5 Merck & Co., Inc. 12.5.1 Merck & Co., Inc. Company Details 12.5.2 Company Description and Business Overview 12.5.3 Non-small Cell Lung Cancer Drugs Introduction 12.5.4 Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business (2014-2019) 12.5.5 Merck & Co., Inc. Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Product (2019-2025) 13.2 Market Size Forecast by Application (2019-2025) 13.3 Market Size Forecast by Regions 13.4 North America 13.5 Europe 13.6 China 13.7 Japan 13.8 Southeast Asia 13.9 India 13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 15.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Non-small Cell Lung Cancer Drugs Key Market Segments Table Key Players Non-small Cell Lung Cancer Drugs Covered Table Global Non-small Cell Lung Cancer Drugs Market Size Growth Rate by Type 2018-2025 (Million US$) Figuer Biologics Figures Table Key Players of Biologics Figuer Small Molecule Targeted Therapy Figures Table Key Players of Small Molecule Targeted Therapy Figuer Chemotherapy Figures Table Key Players of Chemotherapy Figuer Other Figures Table Key Players of Other Table Global Non-small Cell Lung Cancer Drugs Market Size Growth by Application 2019-2025 (Million US$) Figure Global Non-small Cell Lung Cancer Drugs Market Share by Application in 2018 & 2025 Figure Lung Adenocarcinoma Case Studies Figure Squamous Cell Lung Carcinoma Case Studies Figure Large-cell Lung Carcinoma Case Studies Figure Non-small Cell Lung Cancer Drugs Report Years Considered Figure Global Non-small Cell Lung Cancer Drugs Market Size and Growth Rate 2014-2025 (Million US$) Table Global Non-small Cell Lung Cancer Drugs Market Size by Regions 2019-2025 (Million US$) Table Global Non-small Cell Lung Cancer Drugs Market Size by Regions 2019-2025 (Million US$) Table Global Non-small Cell Lung Cancer Drugs Market Share by Regions 2014-2019 Figure Global Non-small Cell Lung Cancer Drugs Market Share by Regions 2014-2019 Figure Global Non-small Cell Lung Cancer Drugs Market Share by Regions in 2018 Table Market Top Trends Table Key Drivers: Impact Analysis (2019-2025) Table Key Challenges Figure PORTER'S FIVE FORCES ANALYSIS Table Global Non-small Cell Lung Cancer Drugs Revenue by by Players (2014-2019) (Million US$) Table Global Non-small Cell Lung Cancer Drugs Market Share by by Players (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Market Share by by Players in 2018 Table Global Non-small Cell Lung Cancer Drugs by Players Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Non-small Cell Lung Cancer Drugs Product/Solution/Service Table Date of Enter into Non-small Cell Lung Cancer Drugs Market Table Mergers & Acquisitions, Expansion Plans Table Global Non-small Cell Lung Cancer Drugs Market Size by Type (2014-2019) (Million US$) Table Global Non-small Cell Lung Cancer Drugs Market Size Share by Type (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Type (2014-2019) Table Global Non-small Cell Lung Cancer Drugs Market Size by Application (2014-2019) (Million US$) Table Global Non-small Cell Lung Cancer Drugs Market Size Share by Application (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Market Size Market Share by Application (2014-2019) Figure Global Non-small Cell Lung Cancer Drugs Revenue Market Share by Application in 2018 Figure North America Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$) Table North America Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$) Table North America Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019) Table North America Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$) Table North America Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019 Table North America Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$) Table North America Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019 Figure Europe Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$) Table Europe Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$) Table Europe Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019) Table Europe Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$) Table Europe Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019 Table Europe Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$) Table Europe Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019 Figure China Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$) Table China Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$) Table China Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019) Table China Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$) Table China Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019 Table China Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$) Table China Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019 Figure Japan Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$) Table Japan Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$) Table Japan Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019) Table Japan Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$) Table Japan Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019 Table Japan Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$) Table Japan Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019 Figure Southeast Asia Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019) Table Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$) Table Southeast Asia Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019 Table Southeast Asia Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$) Table Southeast Asia Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019 Figure India Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$) Table India Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$) Table India Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019) Table India Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$) Table India Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019 Table India Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$) Table India Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019 Figure Central & South America Non-small Cell Lung Cancer Drugs Market Size 2014-2019 (Million US$) Table Central & South America Key Players Non-small Cell Lung Cancer Drugs Revenue (2018-2019) (Million US$) Table Central & South America Key Players Non-small Cell Lung Cancer Drugs Market Share (2018-2019) Table Central & South America Non-small Cell Lung Cancer Drugs Market Size by Type 2014-2019 (Million US$) Table Central & South America Non-small Cell Lung Cancer Drugs Market Share by Type 2014-2019 Table Central & South America Non-small Cell Lung Cancer Drugs Market Size by Application 2014-2019 (Million US$) Table Central & South America Non-small Cell Lung Cancer Drugs Market Share by Application 2014-2019 Table AstraZeneca Company Details Table AstraZeneca Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$) Figure AstraZeneca Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019) Table AstraZeneca Recent Development Table Bristol-Myers Squibb Company Company Details Table Bristol-Myers Squibb Company Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$) Figure Bristol-Myers Squibb Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019) Table Bristol-Myers Squibb Company Recent Development Table Eli Lilly and Company Company Details Table Eli Lilly and Company Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$) Figure Eli Lilly and Company Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019) Table Eli Lilly and Company Recent Development Table F. Hoffmann-La Roche Ltd Company Details Table F. Hoffmann-La Roche Ltd Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$) Figure F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019) Table F. Hoffmann-La Roche Ltd Recent Development Table Merck & Co., Inc. Company Details Table Merck & Co., Inc. Revenue in Non-small Cell Lung Cancer Drugs Business 2014-2019 (Million US$) Figure Merck & Co., Inc. Revenue Growth Rate in Non-small Cell Lung Cancer Drugs Business (2014-2019) Table Merck & Co., Inc. Recent Development Table Global Non-small Cell Lung Cancer Drugs Market Size by Regions (Million US$) 2019-2025 Figure Global Non-small Cell Lung Cancer Drugs Market Size Share by Regions (2019-2025) Figure Global Non-small Cell Lung Cancer Drugs Market Size Share by Regions in 2025 Figure North America Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD) Figure Europe Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD) Figure China Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD) Figure Japan Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD) Figure India Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Non-small Cell Lung Cancer Drugs Market Size Forecast (2019-2025)(Million USD) Table Global Non-small Cell Lung Cancer Drugs Market Size by Product (2019-2025) (Million US$) Figure Global Non-small Cell Lung Cancer Drugs Market Size by Product (2019-2025) Figure Global Non-small Cell Lung Cancer Drugs Market Size by Product in 2025 Table Global Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2025) (Million US$) Figure Global Non-small Cell Lung Cancer Drugs Market Size by Application (2019-2025) Figure Global Non-small Cell Lung Cancer Drugs Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources